LU76367A1 - - Google Patents
Info
- Publication number
- LU76367A1 LU76367A1 LU76367A LU76367A LU76367A1 LU 76367 A1 LU76367 A1 LU 76367A1 LU 76367 A LU76367 A LU 76367A LU 76367 A LU76367 A LU 76367A LU 76367 A1 LU76367 A1 LU 76367A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752556326 DE2556326A1 (de) | 1975-12-13 | 1975-12-13 | Neue pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU76367A1 true LU76367A1 (enrdf_load_html_response) | 1977-06-28 |
Family
ID=5964379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU76367A LU76367A1 (enrdf_load_html_response) | 1975-12-13 | 1976-12-10 |
Country Status (13)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
| ES2289140T3 (es) | 2001-07-16 | 2008-02-01 | F. Hoffmann-La Roche Ag | Derivados de 2-pirrolidona como agonistas de prostanoide. |
| ATE315022T1 (de) | 2001-07-16 | 2006-02-15 | Hoffmann La Roche | Prostaglandinanaloga als ep4-rezeptoragonisten |
| PT1417975E (pt) | 2001-07-23 | 2011-05-30 | Ono Pharmaceutical Co | Medicamentos que cont?m um agonista de ep4 como princ?pio activo destinados a doen?as associadas a perda de massa ?ssea |
| US7402605B2 (en) | 2002-03-05 | 2008-07-22 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| CN1735597A (zh) | 2003-01-10 | 2006-02-15 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素激动剂的2－哌啶酮衍生物 |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
-
1975
- 1975-12-13 DE DE19752556326 patent/DE2556326A1/de active Pending
-
1976
- 1976-12-08 NL NL7613643A patent/NL7613643A/xx not_active Application Discontinuation
- 1976-12-10 SE SE7613948A patent/SE7613948L/xx unknown
- 1976-12-10 ZA ZA767379A patent/ZA767379B/xx unknown
- 1976-12-10 IL IL51090A patent/IL51090A0/xx unknown
- 1976-12-10 LU LU76367A patent/LU76367A1/xx unknown
- 1976-12-10 AU AU20473/76A patent/AU2047376A/en not_active Expired
- 1976-12-10 DK DK554776A patent/DK554776A/da unknown
- 1976-12-13 BE BE173206A patent/BE849346R/xx active
- 1976-12-13 JP JP51148823A patent/JPS5273865A/ja active Pending
- 1976-12-13 FR FR7637469A patent/FR2334352A2/fr active Granted
- 1976-12-13 GB GB51912/76A patent/GB1569982A/en not_active Expired
- 1976-12-13 CA CA267,691A patent/CA1072108A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2334352B2 (enrdf_load_html_response) | 1978-12-08 |
| DK554776A (da) | 1977-06-14 |
| GB1569982A (en) | 1980-06-25 |
| CA1072108A (en) | 1980-02-19 |
| DE2556326A1 (de) | 1977-06-23 |
| JPS5273865A (en) | 1977-06-21 |
| ZA767379B (en) | 1977-11-30 |
| NL7613643A (nl) | 1977-06-15 |
| FR2334352A2 (fr) | 1977-07-08 |
| SE7613948L (sv) | 1977-06-14 |
| BE849346R (fr) | 1977-06-13 |
| IL51090A0 (en) | 1977-02-28 |
| AU2047376A (en) | 1978-06-15 |